CC
ELV icon

Curian Capital’s Elevance Health ELV Stock Holding History

Curian Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-14,542
Closed -$2.03M – 112
2015
Q4 		$2.03M Sell
14,542
-29,917
-67% -$4.12M 0.15% 147
2015
Q3 		$6.22M Sell
44,459
-43,027
-49% -$6.47M 0.17% 154
2015
Q2 		$14.4M Sell
87,486
-29,624
-25% -$4.73M 0.24% 103
2015
Q1 		$18.1M Buy
117,110
+7,662
+7% +$1.09M 0.3% 76
2014
Q4 		$13.8M Buy
109,448
+35,564
+48% +$4.39M 0.23% 99
2014
Q3 		$8.84M Buy
73,884
+2,879
+4% +$330K 0.16% 167
2014
Q2 		$7.64M Buy
71,005
+1,062
+2% +$109K 0.13% 182
2014
Q1 		$6.96M Buy
69,943
+1,817
+3% +$164K 0.12% 190
2013
Q4 		$6.29M Buy
68,126
+1,760
+3% +$156K 0.11% 191
2013
Q3 		$5.55M Buy
+66,366
New +$5.69M 0.1% 194

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Curian Capital's ELV Position: Q1 2016 in Review

Curian Capital sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 14,542 shares — an estimated $2.03M sold.

Curian Capital first reported a position in ELV in Q3 2013 and held it in 10 quarters. The position peaked at $18.1M in Q1 2015. 770 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • Curian Capital reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 14,542 Elevance Health shares in Q1 2016, an estimated $2.03M.
  • Curian Capital first reported a position in Elevance Health in Q3 2013 and held it in 10 quarters.
  • Curian Capital's Elevance Health position peaked at $18.1M in Q1 2015.
  • 770 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.